EFFECT OF PH ON RADIOMETRIC MICS OF CLARITHROMYCIN AGAINST 18 SPECIES OF MYCOBACTERIA

被引:38
作者
RASTOGI, N
GOH, KS
机构
关键词
D O I
10.1128/AAC.36.12.2841
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The antimycobacterial spectrum of clarithromycin, a new macrolide drug, was screened against 26 strains belonging to 18 species of mycobacteria by determining radiometric MICs by Bactec methodology at three different pHs, i.e., pH 6.0, 6.8, and 7.4. The MICs obtained at pH 7.4 were 1 to 2 or more dilutions lower in some of the species than those obtained at pH 6.8, whereas they were significantly higher at pH 6.0. The numbers of species for which MICs were below the C(max) levels of clarithromycin (i.e., 4 mug/ml) at different pHs were 8 of 18 species at pH 6.0, 13 of 18 species at pH 6.8, and 14 of 18 species at pH 7.4. The drug possessed promising activity against such potential pathogens as M. avium, M. scrofulaceum, M. szulgai, M. malmoense, M. xenopi, M. marinum, and M. kansasii and rare pathogens like M. chelonei.
引用
收藏
页码:2841 / 2842
页数:2
相关论文
共 9 条
[1]   CLARITHROMYCIN MINIMAL INHIBITORY AND BACTERICIDAL CONCENTRATIONS AGAINST MYCOBACTERIUM-AVIUM [J].
HEIFETS, LB ;
LINDHOLMLEVY, PJ ;
COMSTOCK, RD .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (04) :856-858
[2]   NEW DIRECTIONS FOR MACROLIDE ANTIBIOTICS - STRUCTURAL MODIFICATIONS AND INVITRO ACTIVITY [J].
KIRST, HA ;
SIDES, GD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (09) :1413-1418
[3]   NEW DIRECTIONS FOR MACROLIDE ANTIBIOTICS - PHARMACOKINETICS AND CLINICAL EFFICACY [J].
KIRST, HA ;
SIDES, GD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (09) :1419-1422
[4]   UPTAKE, ACCUMULATION, AND EGRESS OF ERYTHROMYCIN BY TISSUE-CULTURE CELLS OF HUMAN-ORIGIN [J].
MARTIN, JR ;
JOHNSON, P ;
MILLER, MF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (03) :314-319
[5]   ACTIVITY OF CLARITHROMYCIN COMPARED WITH THOSE OF OTHER DRUGS AGAINST MYCOBACTERIUM-PARATUBERCULOSIS AND FURTHER ENHANCEMENT OF ITS EXTRACELLULAR AND INTRACELLULAR ACTIVITIES BY ETHAMBUTOL [J].
RASTOGI, N ;
GOH, KS ;
LABROUSSE, V .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (12) :2843-2846
[6]   EXTRACELLULAR AND INTRACELLULAR ACTIVITIES OF CLARITHROMYCIN USED ALONE AND IN ASSOCIATION WITH ETHAMBUTOL AND RIFAMPIN AGAINST MYCOBACTERIUM-AVIUM COMPLEX [J].
RASTOGI, N ;
LABROUSSE, V .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (03) :462-470
[7]   INVITRO ACTIVITY OF THE NEW DIFLUORINATED QUINOLONE SPARFLOXACIN (AT-4140) AGAINST MYCOBACTERIUM-TUBERCULOSIS COMPARED WITH ACTIVITIES OF OFLOXACIN AND CIPROFLOXACIN [J].
RASTOGI, N ;
GOH, KS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (09) :1933-1936
[8]   ANTIMYCOBACTERIAL SPECTRUM OF SPARFLOXACIN AND ITS ACTIVITIES ALONE AND IN ASSOCIATION WITH OTHER DRUGS AGAINST MYCOBACTERIUM-AVIUM COMPLEX GROWING EXTRACELLULARLY AND INTRACELLULARLY IN MURINE AND HUMAN MACROPHAGES [J].
RASTOGI, N ;
LABROUSSE, V ;
GOH, KS ;
DESOUSA, JPC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (12) :2473-2480
[9]   INTRACELLULAR-DISTRIBUTION AND ACTIVITY OF ANTIBIOTICS [J].
TULKENS, PM .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (02) :100-106